Replies to post #10779 on GTC Biotherapeutics (fka GTCB)

[DewDiligence]

>…the delay and the "diversion" of the original partner could end being a plus for GTCB… Yes, I know I am a hopeless optimist.<

That’s not at all far-fetched, IMO. The deal GTC ends up striking could well be better than the one that got away.